Ideaya Biosciences (IDYA) said Monday it plans to offer up to $300 million of common stock and, in lieu of common shares, pre-funded warrants in an underwritten public offering.

The company also intends to grant underwriters a 30-day option to purchase up to an additional $45 million of common stock.

Shares of Ideaya were down more than 7% in after-hours trading.